Kurata, Morito
Rathe, Susan K.
Bailey, Natashay J.
Aumann, Natalie K.
Jones, Justine M.
Veldhuijzen, G. Willemijn
Moriarity, Branden S.
Largaespada, David A.
Article History
Received: 12 July 2016
Accepted: 11 October 2016
First Online: 3 November 2016
Competing interests
: There is potential competing Interest. Dr. Largaespada is co-owner and advisor to NeoClone Biotechnology, Inc., B-MoGen Biotechnologies Inc., Recombinetics Inc. and Discovery Genomics, Inc. No resources or personnel from either company were involved in this research in any way. The remaining authors declare no competing financial interest.